Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions
Molecular Pharmaceutics · 04.12.2023 · 20 (12) · 6420-6428
DOI: 10.1021/acs.molpharmaceut.3c00797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 31.10.2023. Verfasst von Yangjie Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Drug Product Technologies, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, California 91320, United States. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Sodium Chloride. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
During the developability assessment of therapeutic monoclonal antibody (mAb) candidates, utilization of robust high-throughput predictive assays enables rapid selection of top candidates with low risks for late-stage development. Predicting the viscosities of highly concentrated mAbs using limited materials is an important aspect of developability assessment because high viscosity can complicate manufacturability, stability, and administration. Here, we report a high-throughput assay measuring protein-protein interactions to predict mAb viscosity. The diffusion interaction parameter (kD) measures colloidal self-association in dilute solutions and has been reported to be predictive of the mAb viscosity at high concentrations. However, kD of Amgen early stage IgG1 mAb candidates measured in 10 mM acetate at pH 5.2 containing sucrose and polysorbate (denoted A52SuT) shows only weak correlation to their viscosities at 140 mg/mL in A52SuT. We hypothesize that kD measured in A52SuT reflects primarily long-range electrostatic repulsions because most of these mAb candidates carry strong net positive charges in this low ionic strength formulation with pH (5.2) well below pI values of mAb candidates. However, the viscosities of high concentration mAbs depend heavily on short-range molecular interactions. We propose an improved kD method in which salt is added to suppress charge repulsions and to allow for detection of key short-range interactions in dilute solutions. Salt types and salt concentrations were screened, and an optimal salt condition was identified. This optimized method was further validated using two test mAb sets. Overall, the method improves the Pearson R2 between kD and viscosity (6-230 cP) from 0.24 to 0.80 for a data set consisting of 37 mAbs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Product Technologies, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, California 91320, United States.
- Molecular Analytics, Biologics Therapeutics Discovery, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, California 91320, United States.
ORCID-Profile: Yangjie Wei
Zitieren
APA
Wei, Y., Qi, W., Maglalang, E., Pelegri-O'Day, E. M., Luong, M., Razinkov, V., & Sloey, C. (2023). Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions. Molecular Pharmaceutics, 20(12), 6420-6428. https://doi.org/10.1021/acs.molpharmaceut.3c00797
Vancouver
Wei Y, Qi W, Maglalang E, Pelegri-O'Day EM, Luong M, Razinkov V, et al. Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions. Molecular Pharmaceutics. 2023;20(12):6420-6428. doi:10.1021/acs.molpharmaceut.3c00797
BibTeX
@article{Wei2023,
author = {Wei, Yangjie and Qi, Wei and Maglalang, Erick and Pelegri-O'Day, Emma M and Luong, Michelle and Razinkov, Vladimir and Sloey, Christopher},
title = {Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions},
journal = {Molecular Pharmaceutics},
year = {2023},
volume = {20},
number = {12},
pages = {6420--6428},
doi = {10.1021/acs.molpharmaceut.3c00797}
}
EUVIMED